Standardized 5-stage Sexual Maturity Rating (SMR) for pediatric pubertal assessment — breast, genital, and pubic hair development
The Tanner (Sexual Maturity Rating, SMR) system, developed by James Tanner and colleagues at the Harpenden Growth Study in the 1960s, provides a standardized clinical vocabulary for describing pubertal development. Stage I is the prepubertal reference point: elevated nipple/papilla only in girls, testicular volume under 4 mL in boys, and no terminal pubic hair. Establishing this baseline accurately is the foundation for recognizing both normal onset and precocious or delayed puberty.
Accurate Tanner staging requires a consistent, reproducible examination:
Breast staging (inspection + palpation): the examiner visually inspects breast contour, then palpates the tissue directly beneath the areola with the patient supine — glandular tissue in early stages can be missed by inspection alone, particularly in patients with adiposity mimicking breast tissue (lipomastia vs. true thelarche).
Genital staging (males): testicular volume is measured by comparison against a Prader orchidometer — a string of ellipsoid beads ranging from 1 to 25 mL. The examiner palpates each testis between thumb and forefinger and matches its size to the closest bead, taking the larger of the two testes as the recorded value.
Pubic hair staging (both sexes): assessed by inspection of hair quantity, coarseness, curl, and area of distribution — independent of breast or genital stage, since pubarche (adrenarche-driven) and gonadarche can proceed on different timelines.
Stage I is also the clinical anchor for diagnosing precocious and delayed puberty:
Precocious puberty: any sign of secondary sexual development (breast budding, testicular enlargement, or pubic hair) before age 8 in girls or age 9 in boys warrants endocrine evaluation — bone age radiograph, LH/FSH and sex-steroid levels, and consideration of a GnRH stimulation test to distinguish central (GnRH-dependent) from peripheral (GnRH-independent) causes.
Delayed puberty: absence of breast development by age 13 in girls, or testicular volume <4 mL by age 14 in boys, is the conventional threshold for further work-up — assessing for constitutional delay of growth and puberty (the most common benign cause), versus hypogonadotropic or hypergonadotropic hypogonadism.
A single accurate Stage I baseline exam, documented with orchidometer volume or breast photography/diagram, is what makes later staging comparisons — and thus timely recognition of precocious or delayed puberty — clinically meaningful.
Stage II marks the clinically recognizable onset of puberty, driven by reactivation of pulsatile GnRH secretion from the hypothalamus after the relative quiescence of mid-childhood. In girls, thelarche (breast budding) is usually the first visible sign, typically between ages 8 and 13. In boys, the earliest reliable sign is not visible at all — it is testicular enlargement to ≥4 mL, typically between ages 9 and 14, often preceding any visible genital or voice change by many months.
Puberty begins centrally, not in the gonad. Across mid-childhood, hypothalamic GnRH pulse generation is actively suppressed (central inhibition, involving kisspeptin/KISS1 neuron quiescence). Puberty onset reflects disinhibition of this system:
1. Kisspeptin neurons in the arcuate and anteroventral periventricular nuclei increase pulsatile signaling to GnRH neurons 2. GnRH is released in increasingly frequent nocturnal pulses, stimulating pituitary gonadotrophs 3. LH and FSH are secreted in a pulsatile, sleep-entrained pattern — nocturnal LH pulses are the earliest detectable hormonal sign of puberty, preceding any physical change 4. LH stimulates gonadal steroidogenesis (Leydig cells in testes, theca cells in ovaries); FSH drives gametogenic support (Sertoli cells, granulosa cells) 5. Rising estradiol (girls) or testosterone (boys) drives the visible Stage II changes
Testicular volume is the single most sensitive clinical marker of pubertal onset in boys, because prepubertal testes are almost entirely composed of immature seminiferous tubules with minimal Sertoli/Leydig cell mass — enlargement directly reflects gonadotropin-driven cellular proliferation.
The Prader orchidometer uses a graded series of ellipsoid volumes (1, 2, 3, 4, 6, 8, 10, 12, 15, 20, 25 mL) for side-by-side comparison against the palpated testis. A volume of 4 mL (roughly the size of a large grape) is the accepted threshold defining Stage II onset.
In girls, the breast bud is a firm, sometimes tender, palpable disc of glandular tissue directly under the areola, elevating the papilla and areola as a single small mound — distinguished from areolar pigmentation change alone, which can occur without true glandular development.
Because nocturnal LH pulsatility precedes any physical sign by months, a boy or girl can already be neuroendocrinologically "in puberty" before Stage II is clinically detectable on exam.
Stage III is characterized by continued breast and areolar enlargement without separation of their contours, early penile length increase in boys, and pubic hair that becomes coarser, darker, and curlier, spreading sparsely over the pubic symphysis. Clinically, Stage III is notable because peak height velocity (PHV) — the fastest point of the pubertal growth spurt — typically occurs here in girls, roughly one to two years earlier than in boys.
The pubertal growth spurt is driven primarily by rising sex-steroid concentrations acting at the epiphyseal growth plate, with a striking biphasic dose-response:
Low-to-moderate estrogen concentrations (early-to-mid puberty): stimulate chondrocyte proliferation and growth hormone/IGF-1 secretion, accelerating linear growth — this is the mechanism of the pubertal growth spurt itself, and it applies to both sexes (estrogen, aromatized from testosterone, drives most of the male growth spurt too).
High, sustained estrogen concentrations (late puberty): promote chondrocyte senescence and progressive growth-plate closure, eventually halting linear growth entirely — the same hormone that accelerates growth in Stage II–III ultimately terminates it by Stage V.
Because girls reach a given estrogen exposure earlier than boys reach the equivalent testosterone/estrogen exposure, PHV occurs roughly two years earlier in the female pubertal sequence — at Tanner III rather than Tanner IV.
Peak height velocity in girls (~8–9 cm/year) typically precedes menarche by about one year — menarche itself is a late pubertal event, usually coinciding with Tanner Stage IV, after the growth spurt has already begun to decelerate.
Pubic hair is staged independently of breast/genital development because pubarche is driven predominantly by adrenal androgens (DHEA, DHEA-S from adrenarche) rather than gonadal sex steroids, and the two axes can be asynchronous:
PH2: sparse, long, lightly pigmented, straight or slightly curled hair, mainly along the labia majora or at the base of the penis.
PH3: hair becomes considerably darker, coarser, and more curled, spreading sparsely over the pubic symphysis — this is the Stage III hallmark.
PH4: adult-type hair in character (coarse, curled) but covering a smaller area than the adult pattern, not yet extending to the medial surface of the thighs.
Because pubarche and thelarche/gonadarche are governed by separate hormonal axes, discordant staging (e.g., advanced pubic hair with prepubertal breasts, or vice versa) is a recognized and usually benign finding, though marked discordance can prompt evaluation for isolated premature adrenarche or an androgen-secreting process.
By Stage IV, the areola and papilla project above the breast contour to form a secondary mound — the classic "double contour" of Tanner IV — while testes continue enlarging (typically 12–15 mL) and the glans penis widens. Pubic hair is adult in texture but has not yet spread to the medial thighs. This stage is where boys reach peak height velocity, roughly two years later in the pubertal sequence than the equivalent female milestone at Stage III.
Boys enter puberty roughly six months to a year later than girls on average, and additionally undergo a longer prepubertal genital/testicular maturation phase before testosterone concentrations reach the threshold needed to trigger peak growth velocity:
• Girls: onset (Tanner II, ~age 10) → PHV at Tanner III (~age 12) — a relatively short interval • Boys: onset (Tanner II, ~age 11.5) → PHV at Tanner IV (~age 14) — a longer interval, because testicular/Leydig cell maturation and the resulting testosterone rise (and its peripheral aromatization to estrogen, the proximate driver of growth-plate stimulation) takes longer to reach growth-promoting concentrations
The net effect: boys begin their growth spurt later and it lasts longer at a higher peak velocity, contributing an additional several centimeters of prepubertal growth time plus a taller peak — the principal explanation for the average adult height difference between men and women.
Genital (male) Tanner staging integrates testicular volume, scrotal changes, and penile dimensions:
G1 (Stage I): prepubertal, testes <4 mL, scrotum and penis proportioned as in childhood. G2 (Stage II): testes 4 mL, scrotal skin reddens and thins; minimal penile change. G3 (Stage III): testes ~8–10 mL; penis increases mainly in length. G4 (Stage IV): testes ~12–15 mL, scrotal skin darkens further; penis increases in length and breadth, glans develops. G5 (Stage V): testes 15–25 mL (adult range), adult penile size and scrotal appearance.
The orchidometer's full 1–25 mL bead range spans this entire trajectory, making it the single quantitative measurement that most precisely tracks male pubertal progression — far more granular than the categorical G1–G5 descriptions alone.
Clinically, a boy already at Tanner IV genital/testicular staging but still pre-PHV on growth charts is an expected, not concerning, pattern — genital maturation reliably precedes the growth spurt peak by design of the HPG-to-growth-plate signaling delay.
Tanner Stage V represents completion of puberty: mature breast contour with the areola receding to the general contour of the breast, adult genital size and shape, and pubic hair reaching adult quantity and quality with distribution extending onto the medial thighs. Growth velocity slows to a near-adult rate of under 2 cm per year as rising, sustained sex-steroid exposure drives progressive fusion of the epiphyseal growth plates toward final adult height.
Stage V is reached independently across the three staging domains, and not always simultaneously:
Breast (B5): the areola recesses back into the general contour of the breast (having projected as a separate secondary mound at B4), with mature glandular volume and shape — final breast size, however, is not fixed at B5 and can continue subtle change into the early twenties.
Genital (G5): testes reach adult volume (15–25 mL) and adult penile length/breadth; scrotal skin is fully adult in pigmentation and texture.
Pubic hair (PH5): adult quantity, coarseness, and curl, now distributed in the classic inverse-triangle (female) or diamond-extending-to-umbilicus (male, sometimes staged as an additional PH6) pattern, spreading onto the medial thighs — the defining distinction from Stage IV.
Because the three domains can complete at slightly different times, a fully "Stage V" designation in clinical notes typically requires each domain to be assessed and recorded separately.
The same sustained sex-steroid exposure that completes secondary sexual characteristics simultaneously closes the epiphyseal growth plates:
• Estrogen (in both sexes, via aromatization of testosterone in boys) is the dominant driver of epiphyseal fusion — this is why estrogen-deficient states (e.g., aromatase deficiency) are associated with continued linear growth and tall final stature despite adult age • Bone age, assessed by hand-wrist radiograph (Greulich-Pyle or Tanner-Whitehouse atlas methods), tracks epiphyseal maturation and is used clinically to predict remaining growth potential and final adult height • By Stage V, bone age typically approximates or exceeds chronological age, and growth plates are radiographically fused or nearly fused, leaving minimal residual growth (a few centimeters at most) • Growth velocity, which peaked at 8–10 cm/year during Stage III–IV, decelerates to under 2 cm/year — the adult baseline rate reflecting only residual vertebral and appositional bone growth
A hand-wrist bone-age radiograph showing fused or near-fused epiphyses is the most direct confirmation that a patient has reached — or is about to reach — final adult height, complementing the clinical Tanner Stage V examination findings.